News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
162 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17849)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Secant Group Announces Collaboration between Orgenesis and Atvio Biotech, a Wholly Owned Subsidiary of Masthercell Global, to Develop and Commercialize Scaffold Technologies for Advanced Cell Therapies
Secant Group and Atvio Biotech to advance project under $1.8 million grant from the Israel-U.S. Binational Industrial R&D Foundation
July 31, 2018
·
5 min read
Ascletis Filed NDA for Its All-oral HCV Treatment
The company expects to receive feedback from the China Food and Drug Administration (CFDA) within five business days.
July 31, 2018
·
1 min read
Business
USF Tampa Bay Technology Incubator Welcomes NeuX Technologies, Inc.
NeuX Technologies, Inc. has joined the Tampa Bay Technology Incubator, part of USF CONNECT, at the University of South Florida.
July 31, 2018
·
3 min read
FDA
Pfizer’s Retacrit, the First Erythropoietin Stimulating Agent to be FDA Approved, Not Likely to See Rapid Adoption in the US Dialysis Market
Two-thirds of surveyed nephrologists do not expect their dialysis center to make Retacrit available for at least a year.
July 31, 2018
·
5 min read
Business
TransCelerate and BioCelerate Launch New Technology Platform to Enable R&D Data Sharing
DataCelerateTM Seamlessly Connects Clean, Converted Clinical & Preclinical Information within One Data Lake Solution
July 31, 2018
·
5 min read
Job Trends
RadianceTx Raises $1 Million First Tranche to Develop Novel Glaucoma Therapy
RadianceTx Beta Ophthalmic System Unlocks the Clinical Potential of Glaucoma Surgical Interventions
July 31, 2018
·
3 min read
Deals
Takeda Reports First Quarter FY2018 Results
Strong start on underlying revenue and profitability led by Growth Drivers and Opex discipline
July 31, 2018
·
10 min read
Business
Essity Restructures in France
To further strengthen competitiveness and increase efficiency, Essity is restructuring its Consumer Tissue production in France
July 31, 2018
·
1 min read
Business
Abzena Signs Protein Engineering Agreement with NYU Langone Health
Abzena plc has entered into a master service agreement with one of America’s leading academic medical centres, NYU Langone Health (New York, US).
July 31, 2018
·
3 min read
Business
Colorectal Cancer Alliance Hires Director of Medical Affairs
Ronit Yarden, Ph.D., will make major contributions to the Alliance’s research programs, education campaigns and more
July 31, 2018
·
3 min read
Previous
11 of 17
Next